Related references
Note: Only part of the references are listed.Limitations of FKBP12.6-directed treatment strategies for maladaptive cardiac remodeling and heart failure
Tim Seidler et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Differential Cardiac Remodeling in Preload Versus Afterload
Karl Toischer et al.
CIRCULATION (2010)
A Novel Endoplasmic Reticulum Export Signal PROLINE AT THE + 2-POSITION FROM THE SIGNAL PEPTIDE CLEAVAGE SITE
Yoshinori Tsukumo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
DYRK1A Is a Novel Negative Regulator of Cardiomyocyte Hypertrophy
Christian Kuhn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-α
Carlton R. Cooper et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Mechanisms of disease: Cardiac plasticity
Joseph A. Hill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
C-reactive protein and incident left ventricular hypertrophy in essential hypertension
Farahnak Assadi
PEDIATRIC CARDIOLOGY (2007)
Differential expression profiling between the relative normal and dystrophic muscle tissues from the same LGMD patient
Yong Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
ERK and beyond - Insights from B-Raf and Raf-1 conditional knockouts
Gergana Galabova-Kovacs et al.
CELL CYCLE (2006)
Regulation and role of Raf-1/B-Raf heterodimerization
LK Rushworth et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization
MJ Garnett et al.
MOLECULAR CELL (2005)
Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)
M Rolfe et al.
BIOCHEMICAL JOURNAL (2005)
Effect of C-reactive protein on gene expression in vascular endothelial cells
QW Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Hypertrophy of the heart - A new therapeutic target?
N Frey et al.
CIRCULATION (2004)
Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload
IS Harris et al.
CIRCULATION (2004)
Expression profiling of human idiopathic dilated cardiomyopathy
R Grzeskowiak et al.
CARDIOVASCULAR RESEARCH (2003)
Cardiac hypertrophy: The good, the bad and the ugly
N Frey et al.
ANNUAL REVIEW OF PHYSIOLOGY (2003)
Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways - MEK-dependent activation of S6K2 in cardiomyocytes
LJ Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cytoplasmic signaling pathways that regulate cardiac hypertrophy
JD Molkentin et al.
ANNUAL REVIEW OF PHYSIOLOGY (2001)
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
OF Bueno et al.
EMBO JOURNAL (2000)
Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy
TL Yue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The CREC family, a novel family of multiple EF-hand, low-affinity Ca2+-binding proteins localised to the secretory pathway of mammalian cells
B Honoré et al.
FEBS LETTERS (2000)
Share Paper
